Effects of Tryptanthrin on Chronic Myeloid Leukemia Cells
Author Information
Author(s): Miao Shan, Shi Xiaopeng, Zhang Hai, Wang Siwang, Sun Jiyuan, Hua Wei, Miao Qing, Zhao Yong, Zhang Caiqin
Primary Institution: Fourth Military Medical University
Hypothesis
Does tryptanthrin have proliferation-attenuating and apoptosis-inducing effects on human chronic myeloid leukemia K562 cells?
Conclusion
Tryptanthrin significantly inhibits the proliferation of K562 cells and induces apoptosis through mitochondrial dysfunction.
Supporting Evidence
- Tryptanthrin inhibited K562 cell proliferation in a time- and dose-dependent manner.
- Apoptotic changes were observed in K562 cells treated with tryptanthrin.
- Flow cytometry analysis showed a significant increase in apoptotic cells after tryptanthrin treatment.
- Tryptanthrin treatment led to a decrease in mitochondrial membrane potential.
- The expression of pro-apoptotic proteins increased while anti-apoptotic proteins decreased after treatment.
Takeaway
Tryptanthrin is a natural substance that can help stop cancer cells from growing and can make them die, which is good for treating leukemia.
Methodology
The study used MTT assays, flow cytometry, and electron microscopy to assess cell proliferation and apoptosis in K562 cells treated with tryptanthrin.
Limitations
The study did not compare the therapeutic effects of tryptanthrin with other treatments in clinical settings.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website